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Cancer is a leading cause of morbidity and mortal-ity in the developing world, with the majority of 
cancer deaths now occurring in low- and middle-in-
come countries (LMICs).1 In 2008, the World Health 
Organization (WHO) global cancer database (GLOBO-
CAN) estimated that approximately 715 600 new cases 
of cancer occur annually in Africa.2 However, despite 
this enormous burden of disease, the capacity for diag-
nosis and treatment of cancer in this region is 
limited.3,4
While some cancers can be treated effectively with 
curative intent with systemic chemotherapy alone, 
the common epithelial cancers seen in both LMICs 
and high-income countries (HICs) all require surgical 
resection of early-stage disease if there is to be a 
chance for long-term cure, particularly breast, cervical, 
colorectal and prostate cancer. The chance of cure is 
dependent on the stage at presentation—the earlier 
the stage, the higher the chance of cure—and the ca-
pacity of the health service to perform adequate sur-
gery. If the primary tumour has metastasised, there is 
no chance of cure, even at cancer centres in HICs. If a 
patient presents with early-stage disease, but there is 
no capacity for effective surgical treatment, the chance 
of cure is zero.
Development of a cancer-care infrastructure in 
LMICs is a complex undertaking requiring the capac-
ity to assess and diagnose cancers accurately (includ-
ing pathology evaluation), and the administration of 
appropriate systemic treatment (chemotherapy, hor-
mone or targeted treatment) and/or radiation. Cancers 
amenable to surgery provide additional challenges for 
care, as they further rely on surgical infrastructure.5,6 
Specialised training in cancer surgery is thus required 
for optimal long-term outcomes.
In Africa in 2008, the most frequent cancer diagno-
sis in men (prostate) and the two most frequent in 
women (breast and uterine cervix) were amenable to 
surgery.7 However, there is evidence that many pa-
tients with potentially surgically resectable cancer 
present late in the course of the disease,3 reducing the 
effectiveness of surgical and medical treatment. 
Rwanda, a small country in Central/Eastern Africa, has 
taken important steps to address this growing burden 
of cancer. In July 2012, Butaro District Hospital 
opened the first dedicated rural cancer treatment cen-
tre in rural East Africa, the Butaro Cancer Center of 
Excellence (BCCOE). This centre has facilities for both 
in- and out-patient care and resources for a more accu-
rate diagnosis of cancer and potentially better out-
comes of treatment. Information from such a centre 
would provide valuable insights into the burden and 
management of surgically resectable cancer in Africa.
The aim of this study was to describe the demo-
graphic characteristics, referral patterns, management 
and outcomes of patients presenting with potentially 
surgically resectable cancers.
METHODS
Study design
This was a retrospective descriptive study using rou-
tinely collected records of a cohort of patients present-
ing with potentially surgically resectable cancers, de-
fined as cancers where surgery is a required 
component of care for patients with early-stage 
disease.
Setting
General
Rwanda remains Africa’s most densely populated 
country, with an estimated population of 11 million, 
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Setting: Butaro Cancer Centre of Excellence (BCCOE), 
Burera District, Rwanda.
Objectives: To describe characteristics, management 
and 6-month outcome of adult patients presenting with 
potentially surgically resectable cancers.
Design: Retrospective cohort study of patients present-
ing between 1 July and 31 December 2012.
Results: Of 278 patients, 76.6% were female, 51.4% 
were aged 50 –74 years and 75% were referred from 
other district or tertiary hospitals in Rwanda. For the 250 
patients with treatment details, 115 (46%) underwent 
surgery, with or without chemotherapy/radiotherapy. 
Median time from admission to surgery was 21 days (IQR 
2–91). Breast cancer was the most common type of can-
cer treated at BCCOE, while other forms of cancer (cervi-
cal, colorectal and head and neck) were mainly operated 
on in tertiary facilities. Ninety-nine patients had no treat-
ment; 52% of these were referred out within 6 months, 
primarily for palliative care. At 6 months, 6.8% had died 
or were lost to follow-up.
Conclusion: Surgical care was provided for many cancer 
patients referred to BCCOE. However, challenges such as 
inadequate surgical infrastructure and skills, and patients 
presenting late with advanced and unresectable disease 
can limit the ability to manage all cases. This study high-
lights opportunities and challenges in cancer care rele-
vant to other hospitals in rural settings.
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expected to rise to 16 million by 2020.8 A combina-
tion of a growing population, increasing life expec-
tancy, better control of communicable diseases and 
rising standards of living have resulted in cancers and 
other non-communicable diseases rapidly becoming a 
major health concern, a situation common in other 
LMICs.5,9
Site
Rwanda has five tertiary and 40 district hospitals. The 
BCCOE, established in mid-2012 in Butaro District 
Hospital, is supported by Partners In Health, a US-
based non-governmental organization, and its sister 
organisation Inshuti Mu Buzima, a Rwandan-based 
non-governmental organisation. It aims to provide a 
comprehensive range of diagnostic and treatment ser-
vices for patients with cancer, and to be the first facil-
ity to implement standardised training in cancer care 
using protocols that will be included in Rwanda’s 
forthcoming new national guidelines.
The centre staff includes two internists, one general 
surgeon and one gynaecologist (both shared with the 
district hospital for general surgical/gynaecological 
needs), two general practitioners and 10–13 nurses. 
Additional support is available from visiting interna-
tional pathologists, surgeons, oncologists and oncol-
ogy nurses. Services offered include 22 beds for in-pa-
tient care, biopsies and on-site histopathology 
(augmented by sending specimens abroad for special 
staining procedures, as previously described10). Onsite 
imaging includes ultrasound and X-ray, with com-
puted tomography (CT) and medical resonance imag-
ing (MRI) scans available in the capital city (Kigali) 
where necessary. General surgery is available at BC-
COE, while specialised surgery is available at tertiary 
hospitals in Kigali. Chemotherapy is delivered by in-
ternists and supervised by a network of visiting oncol-
ogists, with weekly remote consultation from US-based 
oncology specialists. Radiotherapy is performed in 
neighbouring Uganda. Social support includes health 
facility transportation, nutritional supplementation 
and additional support for poor patients, such as home 
construction. Palliative care is often provided at a dis-
trict hospital closer to the patient’s residence. Patients 
usually access the BCCOE through referral from other 
health facilities in Rwanda or from outside the country 
(primarily Burundi and the Democratic Republic of 
Congo).
Clinical information on in- and out-patients is col-
lected in paper-based medical files. From these, se-
lected data are entered by a data officer into an elec-
tronic medical record (EMR), which can serve as a 
clinical database. Information about surgical proce-
dures is currently kept in the patient’s medical files.
Study population
All adult patients aged 18 years with potentially sur-
gically resectable cancers enrolled in care at the BC-
COE, Rwanda, between 1 July and 31 December 2012 
were included in the study. Individuals included in the 
database might have had cancers amenable to surgery 
if they had presented early enough, but are included 
irrespective of stage of disease.
Source of data, data collection and analysis
Variables extracted from the EMR included demo-
graphics; type and perceived stage of cancer (con-
firmed stage not available, perceived stage based on 
clinical assessment, indicating the clinician’s percep-
tion of disease severity but not necessarily matched to 
a specific staging system); type of facility from which 
patient was referred; and 6-month outcomes—alive, 
dead, referred elsewhere for care or lost to follow-up 
(defined in this study as not attending scheduled clinic 
visits after 6 months). In patients alive at 6 months, 
data available on patient progress (improvement, no 
evidence of disease, progression of cancer) were ex-
tracted from the EMR. Incomplete and inconsistent 
data from the EMR were completed or verified from 
patient paper records. Data on the method of diagno-
sis (histopathology or clinical) and medical treatment 
(surgical intervention, chemotherapy or combined sur-
gery and chemotherapy) were extracted from the pa-
tient files into Excel® (Microsoft Corp, Redmond, WA, 
USA). Patient data were collected in November 2013.
Analyses were completed using Stata v12 (Stata Cor-
poration, College Station, TX, USA). Frequencies and 
proportions of patient characteristics at admission to 
BCCOE, patient management and patient 6-month 
outcomes are presented.
Ethics
The study received technical approval from the Na-
tional Health Research Committee. Ethics approval 
was obtained from the Rwanda National Ethics Com-
mittee and the Ethics Advisory Group of the Interna-
tional Union Against Tuberculosis and Lung Disease, 
Paris, France. The study also met the Médecins Sans 
Frontières Ethics Review Board-approved criteria for 
analysis of routinely collected programme data.
RESULTS
There were 278 patients enrolled in the oncology pro-
gramme at BCCOE with potentially surgically resect-
able cancers. Socio-demographic and clinical charac-
teristics are shown in Table 1. The majority (76.6%) of 
the patients were female, and 143 (51.4%) were aged 
between 50 and 74 years (median age 53 years). 
Among patients with residence records, most (74.9%) 
were from outside Burera District, Rwanda. The most 
common surgically resectable cancers were breast, cer-
vical, head and neck, colorectal and gastric cancers.
Fifty-eight per cent of diagnoses were based on his-
topathology. If uterine cervical cancers are excluded, 
this rises to 70.4%. (Cervical cancer in Rwanda can of-
ten be diagnosed clinically.)
Treatment and timing of surgery are shown in Table 
2. Of the 250 patients with treatment data, 115 (46%) 
underwent surgery either alone or with chemotherapy 
and/or radiotherapy, and an additional 36 (14.4%) un-
derwent chemotherapy and/or radiotherapy without 
surgery. Ninety-nine (39.6%) patients had no treat-
ment. Of these, 51/99 (51.5%) were referred to another 
facility for care, primarily due to advanced disease and 
the need for palliative care, eight died before treat-
ment was started and the remainder had not started 
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treatment during the study period. Presumed staging at presenta-
tion was only available for 99 patients, with surgery data available 
for 96. Of the 39 with presumed Stage 1/2, 24 (61.5%) received 
surgery compared to 22/57 (38.6%) with presumed Stage 3/4 (P = 
0.027).
Of the 76 patients who underwent surgery at BCCOE, nearly 
70% did so within 3 months of initial presentation. The median 
time from presentation to surgery was 21 days (interquartile range 
[IQR] 2–99). Surgical treatment in relation to different types of 
cancer and place of surgery is shown in Table 3. A total of 150 pa-
tients (56.6% of total) had no surgery. Breast cancer was the most 
common type of cancer operated on in BCCOE. Thirty-five of the 
115 patients who had surgery (30.4%) did so outside BCCOE, in-
cluding 5/7 head and neck cancer surgeries and 3/5 colorectal 
cancer surgeries.
Six-month treatment outcomes are shown in Table 4. Most pa-
tients (66.2%) were still in care at BCCOE, and 27% had been re-
ferred out for care. Nineteen patients (6.8% of total) had an ad-
verse outcome of death or loss to follow-up. Limiting the analysis 
to cancer types with 20 cases, there was variability in outcome, 
with breast cancer having the highest rate of enrolment in care at 
6 months (83.2%) and cervical cancer having the highest rates of 
referral out for care (40.9%). Only two patients were documented 
to have died after receiving surgery, and both deaths occurred 
several months after surgery, suggesting that post-operative mor-
tality (mortality within 30 days of surgery) in these patients was 
low. Of those patients still in care and for whom information was 
known, 73.4% were well and had no clinical evidence of disease 
or were improving.
DISCUSSION
This study describes the profile and management of potentially 
surgically resectable cancers at BCCOE, the first dedicated cancer 
treatment centre in rural East Africa. During its first 6 months, the 
centre admitted 278 patients with cancers for which surgery plays 
an important role in early-stage disease. Breast cancer, followed 
by cervical cancer and head and neck cancer were the most com-
mon cancers seen. Over half of the patients had histopathological 
diagnoses recorded in their charts. This is probably a lower bound 
for the proportion with histopathology, as it is possible that a di-
agnosis was received but not documented in the patient file. 
However, the percentage with confirmed histopathology diagno-
sis is still higher than that reported from other sub-Saharan Afri-
can countries with similarly low resources.11,12
The focus of this study was cancers for which surgery for ear-
ly-stage patients is an essential component of treatment; however, 
it is possible that the patients described presented with disease 
too advanced for surgery to be applicable. Approximately 40% of 
the patients did not receive any treatment in the centre; most of 
these were referred to another facility nearer to their homes for 
palliative care. Without details on clinical staging for the remain-
ing patients, it is difficult to know whether surgery was not re-
ceived due to late presentation or due to the lack of availability of 
services.
Of those undergoing treatment, the majority had surgery with 
or without adjunctive chemotherapy or radiotherapy, as appropri-
TABLE 1 Socio-demographic and clinical characteristics of patients 
presenting at BCCOE, Rwanda, with surgically resectable cancers, 
July–December 2012
n (%)
Total 278 
Sex
 Male 65 (23.4)
 Female 213 (76.6)
Age, years
 35 31 (11.1)
 35–49 82 (29.5)
 50–74 143 (51.4)
 75 22 (7.9)
Residence (n = 271)
 Burera District serving BCCOE 26 (9.6)
 Kigali city 38 (14)
 Other districts 203 (74.9)
 Outside Rwanda 4 (1.5)
Referral centre (n = 236)
 Health centre 29 (12.3)
 District hospital 125 (53)
 Tertiary hospital 68 (28.8)
 Outside Rwanda 1 (0.4)
 Not referred 13 (5.5)
Type of diagnosis (n = 274)
 Pathological diagnosis 160 (58.4)
 Clinical diagnosis 114 (41.6)
Cancer type
 Breast 101 (36.3)
 Cervical 60 (21.6)
 Head & neck 20 (6.7)
 Colorectal 9 (3.2)
 Gastric 9 (3.2)
 Prostate 6 (2.2)
 Other * 73 (26.3)
* Lung cancer, sarcomas (such as Ewing’s sarcoma, rhabdomyosarcoma, osteosar-
coma), squamous cell carcinoma, melanoma, ovarian cancer, penile cancer, vulvar 
and endometrial cancer and glioblastoma.
BCCOE = Butaro Cancer Center of Excellence.
TABLE 2 Treatment and timing of surgery for surgically resectable 
cancers in patients presenting at BCCOE, Rwanda, July–December 
2012
Treatment and timing of surgery n (%)
Total 278 
Type of treatment (n = 250)
 Surgery only 41 (16.4)
 Surgery and chemotherapy and/or radiotherapy 65 (26)
 Surgery with unknown chemotherapy/radiotherapy 9 (3.6)
 Chemotherapy and radiotherapy only 10 (4)
 Chemotherapy only 22 (8.8)
 Radiotherapy only 2 (0.8)
 Chemotherapy/radiotherapy with surgery unknown 2 (0.8)
 No treatment 99 (39.6)
  If no treatment, referred out by 6 months 51 (51.5)
  If no treatment, died by 6 months 8 (8.1)
For patients receiving surgery (n = 115)
 Surgery before admission to BCCOE 25 (21.7)
 Surgery within 3 months of presentation 60 (52.3)
 Surgery between 3 and 6 months of presentation 10 (8.7)
 Surgery after 6 months of presentation 10 (8.7)
 Surgery, but date uncertain 10 (8.7)
BCCOE = Butaro Cancer Center of Excellence.
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ate. Breast cancer was the most common type of cancer operated 
on at our centre, while other forms of cancer, such as colorectal 
and head and neck cancer, were mainly operated on in other fa-
cilities. This reflects the inconsistent availability of surgical exper-
tise to deal with these cancers at BCCOE. Six-month outcomes 
were generally good for those who remained in care, with few pa-
tients known to have died and only one patient lost to follow-up.
The strengths of this study lie in the fact that all consecutive 
patients enrolled in care at BCCOE were included, and thus there 
was no special selection of patients. Due attention was also paid 
to internationally agreed recommendations for reporting on ob-
servational studies.13 Limitations relate to the operational nature 
of this record review, with certain variables for which it would be 
important to have information not being available and data miss-
ing for other variables. We believe that the missing data are a 
function of adopting new data collection tools and that they are 
probably missing randomly. Another limitation is that the results 
reflect the burden of cancer among patients presenting at BCCOE 
and do not necessarily reflect the general incidence of these can-
cers in the population or presentation and/or management at 
other sites.
Several policy implications are derived from this study. First, 
many patients did not undergo surgery, possibly due to late pre-
sentation or to the limited surgical resources available at BCCOE. 
Surgical resources in Butaro are shared across all programmes, in-
cluding BCCOE, and between 1 July 2012 and 30 June 2013, 1018 
surgical procedures were completed, with an average of 2–3 per 
day. There are only two operating rooms, and at time of writing 
73 people were on the waiting list for surgery. These limitations 
apply to all surgical patients, and the capacity to manage the de-
mand for surgically resectable cancer is currently lacking. During 
the period of this study, there was permanent capacity for breast 
and cervical cancer surgeries, but other cancer-related surgeries 
could only be performed by visiting specialists. The centre needs 
to decide whether and how to bridge this gap. The most realistic 
solution would be to identify promising health care professionals 
in Rwanda and ensure that they have the appropriate training 
and resources to eventually staff the centre. Treatment efforts 
should be coupled with prevention efforts, such as the promotion 
and use of vaccines against human papillomavirus (HPV) to pre-
vent cervical neoplasia,14 to reduce future demand for treatment 
at BCCOE. Furthermore, and most importantly, these efforts must 
be coupled with a comprehensive screening programme that in-
cludes community education and training of primary health care 
staff, to ensure early presentation of patients, increasing the likeli-
hood of long-term disease-free survival.
Second, the data collection system needs to be strengthened. 
Variables essential for evaluating innovation and progress need to 
be decided on, and ultimately it is best to capture all information 
in an electronic database system. Current revisions and structur-
ing of patient charts should encourage more complete and reli-
able data collection in the future. Ongoing monitoring and evalu-
ation of these efforts is critical to know what is being 
accomplished, where gaps in care persist and how to design inter-
ventions to improve outcomes in the future.
Third, the centre’s vision is to develop standardised cancer 
training and protocols that will be included in Rwanda’s forth-
coming new national guidelines. To realise this vision, rigorous 
documentation of experience, challenges, patient characteristics 
and outcomes in the centre and a continued close relationship 
with the leadership at the Rwandan Ministry of Health are re-
quired. Future research must explore long-term outcomes of these 
patients by cancer type and stage, and should explore the costs of 
different aspects of the oncology programme. Finally, resources 
are needed to support the expansion of services at BCCOE.
BCCOE is unique in being one of the first centres to offer cancer 
services in a rural setting in Africa. Early results are promising, but 
they highlight challenges and possible ways forward for BCCOE 
TABLE 3 Surgical procedures and location by cancer type
Types of surgically 
resectable cancer
No surgery performed*  
n (%)
Location of surgery
Unknown location  
n (%)
Total  
n
At BCCOE  
n (%)
Outside BCCOE†  
n (%)
Breast 34 (35) 50 (51.6) 11 (11.3) 2 (2.1) 97
Cervical 45 (76.3) 6 (10.17) 7 (11.9) 1 (1.7) 59
Head and neck 13 (65) 2 (10) 5 (25) 0 (0) 20
Colorectal 3 (37.5) 2 (25) 3 (37.5) 0 (0) 8
Gastric 6 (66.7) 0 (0) 2 (22.2) 1 (11.1) 9
Prostate 5 (83.3) 0 (0) 1 (16.7) 0 (0) 6
Other 44 (69.5) 16 (22.2) 6 (9.1) 0 (0) 66
 Total 150 (56.6) 76 (28.7) 35 (13.2) 4 (1.5) 265
* Includes patients who received chemotherapy and/or radiotherapy, those who did not receive chemotherapy or radiotherapy, and those for whom treatment with chemo-
therapy or radiotherapy is unknown.
† Surgery was performed either before admission to BCCOE or after referral to a tertiary care facility.
BCCOE = Butaro Cancer Center of Excellence.
TABLE 4 Six-month outcomes for patients with potentially 
surgically resectable cancers at BCCOE, Rwanda
Outcomes n (%)
Total 278 
Outcome at 6 months
 Enrolled in care 184 (66.2)
 Referred out to tertiary health facility for care 75 (27)
 Died 18 (6.5)
 Lost to follow-up 1 (0.3)
For those enrolled in care at 6 months with known  
 disease status (n = 57)
  Well and no evidence of disease 27 (47.4)
  Improving 15 (26.3)
  Stable disease 4 (7)
  Progressing disease 11 (19.3)
BCCOE = Butaro Cancer Center of Excellence.
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and other rural hospitals interested in adopting cancer care. Having 
or developing sufficient surgical infrastructure should be consid-
ered alongside the development of oncology programmes to maxi-
mise the benefits to patients with these highly curable cancers.
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Contexte  :  Centre anticancéreux d’excellence de Butaro (BCCOE), 
District de Butera, Rwanda.
Objectifs  :  Décrire les caractéristiques, la prise en charge et les 
résultats à 6 mois de patients adultes se présentant avec des cancers 
potentiellement extirpables par chirurgie.
Schema  :  Etude rétrospective de cohorte des patients admis entre le 
1er juillet et le 31 décembre 2012.
Resultats  :  Sur 278 patients, 76,6% étaient des femmes, 51,4% 
étaient âgés entre 50 et 74 ans et 75% étaient référés d’un autre 
district ou d’un hôpital tertiaire du Rwanda. Parmi les 250 patients 
dont les traitements étaient connus, 115 (46%) ont bénéficié d’une 
intervention chirurgicale avec ou sans chimiothérapie/radiothérapie. 
Le temps médian écoulé entre l’admission et la chirurgie était de 21 
jours (IQR 2 à 91). Le cancer du sein était le plus fréquent des cancers 
traités au BCCOE, tandis que les autres cancers (col utérin, colorectal 
et tumeur cérébrale ou cervicale) étaient généralement opérés dans 
des hôpitaux tertiaires. Quatre-vingt-dix-neuf patients n’ont eu aucun 
traitement ; 52% ont été référés à l’extérieur dans les 6 mois, 
généralement pour un traitement palliatif. A 6 mois, 6,8% étaient 
décédés ou perdus de vue.
Conclusion  :  De nombreux patients référés au BCCOE pour cancer 
ont bénéficié d’une intervention chirurgicale. Cependant la prise en 
charge de tous les cas est confrontée à la limite de capacité 
chirurgicale et au problème des patients admis tardivement avec un 
cancer avancé et non extirpable. Cette étude met en lumière les 
opportunités et les défis de la prise en charge des cancers pour les 
hôpitaux situés en zone rurale.  
Marco de Referencia: El Centro Butaro de Excelencia en Cáncer 
(BCCOE) del distrito de Burera, en Ruanda.
Objetivos: Describir las características, el manejo y el desenlace 
clínico a los 6 meses de pacientes adultos que se presentaron con 
cánceres cuyo tratamiento quirúrgico podía ser viable.
Métodos: Fue este un estudio retrospectivo de cohortes de los 
pacientes que acudieron al centro entre el 1° de julio y el 31 de 
diciembre del 2012.
Resultados: Se incluyeron en el estudio 278 pacientes, de los cuales 
76,6% eran de sexo femenino, 51,4% tenían entre 50 y 74 años de 
edad y 75% habían sido remitidos de otro hospital distrital o de 
centros de atención terciaria de Ruanda. De los 250 expedientes que 
contaban con detalles sobre el tratamiento, en 115 casos (46%) los 
pacientes recibieron tratamiento quirúrgico con o sin quimioterapia o 
radioterapia. La mediana del lapso entre la hospitalización y la cirugía 
fue 21 días (intervalo intercuartil de 2 a 91). El cáncer de mama fue el 
tipo más frecuente de cáncer que se trató en el BCCOE y la cirugía de 
otras formas de cáncer (cuello uterino, colorrectal y de cara y cuello) 
se realizó principalmente en centros de atención terciaria. Noventa y 
nueve pacientes no recibieron tratamiento; el 52% de estos se remitió 
a otras instituciones en los primeros 6 meses, esencialmente con el 
propósito de recibir tratamiento paliativo. A los 6 meses, el 6,8% de 
los pacientes había fallecido o se habían perdido durante el 
seguimiento.
Conclusión: Muchos de los pacientes remitidos recibieron 
tratamiento quirúrgico en el BCCOE. Sin embargo, la posibilidad de 
tratar todos los casos se ve limitada por obstáculos como una 
capacidad quirúrgica inadecuada y el hecho de que los pacientes 
acuden tarde, en una fase avanzada de la enfermedad, con un cáncer 
inoperable. El presente estudio pone de relieve oportunidades y 
dificultades en el tratamiento del cáncer que son pertinentes para 
otros centros hospitalarios en un entorno rural.
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